Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2025 as amended we wish to inform that CRISIL Ratings Limited ("CRISIL") has upgraded its ratings on the Bank Loan Facilities of Emcure Pharmaceuticals Limited.
हाल में देखा गया
सब क्लियर करें